Eurolyser Diagnostics - Premium Laboratory Equipment

SDMA: A new veterinary assay for evaluation of chronic kidney diseases

Tuesday, 18. August 2020

Eurolyser presents its new parameter for the measurement of SDMA (Symmetric dimethylarginine).

The parameter

Symmetric dimethylarginine (SDMA) is a methylated arginine amino acid. SDMA is derived from intranuclear methylation of L-arginine residues and is released into the cytoplasm after proteolysis. SDMA is correlating with glomerular filtration rate (GFR). On average, SDMA increases in chronic kidney disease (CKD) with 30 to 40% loss of kidney function. Creatinine, however, does not increase until 75% of kidney function is lost. SDMA is therefore an earlier diagnostic tool than Creatinine or Cystatin C.

Your advantages

  • Easy test procedure
  • Results in < 8 minutes
  • In-house analysis
  • Decisive results

Method

Homogeneous, immunturbidimetric test.

Measurement range

7.5 – 100 μg/dl

For more information, please visit the SDMA test kit page

Eurolyser News

18. August 2020

SDMA: A new veterinary assay for evaluation of chronic kidney diseases...
» Read more...

17. August 2020

Phenobarbital: A next generation epilepsy monitoring assay...
» Read more...

10. December 2019

Launch of bidirectional connectivity: a feature for CUBE series instruments...
» Read more...

9. December 2019

PSA (prostate-specific antigen) test: A new assay for prostate cancer screening...
» Read more...